Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

SEC Filing · DEF 14C

FOXO TECHNOLOGIES INC.

FOXOOTCEQUITYCurrent

SEC Filing

Filed Aug 24, 2026Accepted Aug 24, 2026, 5:17 PM EDTCIK 1812360Accession 0001493152-26-039857
Share

Company context

We are a healthcare services and technology company operating in three reportable business segments: (i) Healthcare, (ii) Life Science Services and (iii) Labs, formerly referred to as Labs and Life. These segments further operate in four synergistic divisions, a rural hospital division and a mental and behavioral health division, which make up our Healthcare segment, a biospecimens division, which makes up our Life Science Services segment and an epigenetics diagnostics and interpretation division, which makes up our Labs segment. Our rural hospital division, biospecimens division and epigenetics diagnostics and interpretation division operate through wholly owned subsidiaries, and our behavioral health division operates through a majority-owned subsidiary.

Current securities

Historical securities (5)

Recent company filings

  1. PRE 14C filingAug 14, 2026
  2. 10-Q filingAug 14, 2026
  3. Submission of Matters to a Vote of Security HoldersAug 14, 2026
  4. Regulation FD DisclosureJul 29, 2026
  5. Entry into a Material Definitive AgreementJul 27, 2026

As-filed source

Primary evidence